IP Library › Granted Patent US 8,167,854
Granted Patent B2
US 8,167,854 · App. 12/477,840 · Granted May 1, 2012

Implantable drug reservoir and device having an implantable drug reservoir

Assignee: Biotronik VI Patent AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,167,854
App. No.
12/477,840
Granted
May 1, 2012
Kind
B2
Abstract

The invention relates to an implantable drug reservoir ( 10 ) having a cavity ( 28 ) enclosed by a sheathing ( 12 ) and arranged between a proximal end ( 14 ) and a distal end ( 16 ) for storing one or more drugs ( 50 ), having an outlet opening ( 24 ) for the drug(s) ( 50 ). The drug(s) ( 50 ) can be delivered to a delivery region ( 70 ) through a puncture device ( 20 ) at one end ( 16 ). The invention also relates to a device ( 100 ) having a drug reservoir ( 10 ).

Claims (14)

1. An implantable drug reservoir ( 10 ) having a cavity ( 28 ) surrounded by a sheathing ( 12 ) and arranged between a proximal end ( 14 ) and a distal end ( 16 ) for storing one or more drugs ( 50 ); and an outlet operating ( 24 ) for the drug(s) ( 50 ); characterized in that a puncture device ( 20 ) through which the drug(s) ( 50 ) can be delivered into a deliver region ( 70 ) is provided at one end 16 and the sheathing ( 12 ) is formed from a biodegradable polymer; characterized in that at least one coupling element and/or stabilizing element ( 31 ) is provided for coupling the drug reservoir ( 10 ) in or on the drug delivery region ( 70 ); and characterized in that wing elements ( 34 , 36 ) are provided for stabilization across the longitudinal extent ( 26 ) of the drug reservoir ( 10 ), these wings being hinged along the longitudinal extent ( 26 ) and movable toward one another to enclose between them a portion of tissue to which the drug reservoir ( 10 ) can be connected at its distal end ( 16 ).

2. The device drug reservoir according to claim 1 , characterized in that the wing elements ( 34 , 36 ) are hinged together along the longitudinal extent ( 26 ).

3. The drug reservoir according to claim 1 , characterized in that the puncture device ( 20 ) is formed from a metallic material.

4. The drug reservoir according to claim 1 , characterized in that a swellable material is arranged in the cavity ( 28 ) on the proximal end ( 14 ), forcing the drug ( 50 ) which is between the swellable material and the distal end ( 16 ) out of the outlet opening ( 24 ) through swelling.

5. The drug reservoir according to claim 4 , characterized in that a porous closure ( 40 ) on the proximal end ( 14 ) closes the cavity ( 28 ).

6. The drug reservoir according to claim 1 , characterized in that a shoulder ( 60 ) which widens in diameter away from the sheathing ( 12 ) is formed on the proximal end ( 14 ).

7. The drug reservoir according to claim 6 , characterized in that the shoulder ( 60 ) is designed to be radiopaque in at least some areas.

8. An implantable drug reservoir ( 10 ) having a cavity ( 28 ) surrounded by a sheathing ( 12 ) and arranged between a proximal end ( 14 ) and a distal end ( 16 ) for storing one or more drugs ( 50 ); and an outlet opening ( 24 ) for the drug(s) ( 50 ); characterized in that a puncture device ( 20 ) through which the drug(s) ( 50 ) can be delivered into a delivery region ( 70 ) is provided at one end ( 16 ) and the sheathing ( 12 ) is formed from a biodegradable polymer; characterized in that hooks ( 33 ) are or can be formed on the distal end ( 16 ) for anchoring on or in the drug delivery region ( 70 ); and characterized in that wires ( 32 ) which can be pushed through the outlet opening ( 24 ) on the distal end ( 16 ) for anchoring on or in the drug delivery region ( 70 ) extend through the cavity ( 28 ) to the proximal end ( 14 ) of the sheathing ( 12 ).

9. The drug reservoir according to claim 8 , characterized in that the wires ( 32 ) are formed from shape memory material in at least some areas.

10. The drug reservoir according to claim 8 , characterized in that the puncture device ( 20 ) is formed from a metallic material.

11. The drug reservoir according to claim 8 , characterized in that a swellable material is arranged in the cavity ( 28 ) on the proximal end ( 14 ), forcing the drug ( 50 ) which is between the swellable material and the distal end ( 16 ) out of the outlet opening ( 24 ) through swelling.

12. The drug reservoir according to claim 11 , characterized in that a porous closure ( 40 ) on the proximal end ( 14 ) closes the cavity ( 28 ).

13. The drug reservoir according to claim 8 , characterized in that a shoulder ( 60 ) which widens in diameter away from the sheathing ( 12 ) is formed on the proximal end ( 14 ).

14. The drug reservoir according to claim 13 , characterized in that the shoulder ( 60 ) is designed to be radiopaque in at least some areas.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2018
From: BIOTRONIK VI PATENT AG
To: BIOTRONIK AG
Reel/Frame 045853/0610 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2009
From: FARGAHI, AMIR; TITTELBACH, MICHAEL; HARDER, CLAUS, DR.
To: BIOTRONIK VI PATENT AG
Reel/Frame 022787/0657 →
Priority Claims (1)
DE 10 2008 002 396 · Jun 12, 2008 · national
Continuity (1)
Related Publication 20090312721A1 · Dec 17, 2009